Sanj K. Patel, CHAIRMAN & CEO at Kiniksa Pharmaceuticals International, plc (KNSA), sold 48,565 shares at $54.02 ($2.6M) on 2026-05-01, disclosed to the SEC on 2026-05-01.
Scheduled sale ($2.6M) by CHAIRMAN & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KNSA | SELL | 2025-10-22 | $20.0M | — | Filing → |
| KNSA | SELL | 2025-05-28 | $4.6M | — | Filing → |
| KNSA | SELL | 2025-05-22 | $127K | — | Filing → |